Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$33.32 - $40.98 $79 Million - $97.2 Million
-2,370,993 Reduced 24.0%
7,509,348 $267 Million
Q4 2022

Feb 13, 2023

BUY
$25.32 - $51.45 $10.8 Million - $22 Million
428,133 Added 4.53%
9,880,341 $362 Million
Q3 2022

Nov 14, 2022

BUY
$46.5 - $79.14 $23.2 Million - $39.4 Million
498,086 Added 5.56%
9,452,208 $446 Million
Q2 2022

Aug 15, 2022

SELL
$63.06 - $84.75 $30.1 Million - $40.4 Million
-476,813 Reduced 5.06%
8,954,122 $642 Million
Q1 2022

May 16, 2022

SELL
$74.15 - $99.36 $15.2 Million - $20.4 Million
-205,075 Reduced 2.13%
9,430,935 $763 Million
Q4 2021

Feb 11, 2022

SELL
$86.01 - $102.89 $24.9 Million - $29.7 Million
-288,965 Reduced 2.91%
9,636,010 $989 Million
Q3 2021

Nov 15, 2021

SELL
$84.7 - $96.31 $72.1 Million - $82 Million
-851,643 Reduced 7.9%
9,924,975 $868 Million
Q2 2021

Aug 16, 2021

BUY
$76.44 - $89.57 $212 Million - $249 Million
2,779,522 Added 34.76%
10,776,618 $964 Million
Q1 2021

May 17, 2021

BUY
$67.36 - $80.76 $449 Million - $538 Million
6,663,775 Added 499.79%
7,997,096 $607 Million
Q4 2020

Feb 12, 2021

BUY
$53.08 - $69.86 $63.7 Million - $83.8 Million
1,199,797 Added 898.56%
1,333,321 $90.8 Million
Q3 2020

Nov 16, 2020

SELL
$51.29 - $65.09 $42 Million - $53.3 Million
-819,075 Reduced 85.98%
133,524 $7.1 Million
Q2 2020

Aug 14, 2020

SELL
$34.32 - $62.43 $4.19 Million - $7.62 Million
-122,069 Reduced 11.36%
952,599 $55.5 Million
Q1 2020

May 14, 2020

SELL
$32.64 - $73.63 $22.8 Million - $51.3 Million
-697,325 Reduced 39.35%
1,074,668 $42.4 Million
Q4 2019

Feb 11, 2020

BUY
$48.0 - $59.55 $85.1 Million - $106 Million
1,771,993 New
1,771,993 $105 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.